Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model

British Journal of Dermatology

Volumn 156, Issue 2, 2007, Pages 241-246

  Takano, N ^a   Sakurai, T ^a   Ohashi, Y ^a   Kurachi, M ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

AG879; Atopic dermatitis; K252a; NC Nga mouse; Nerve growth factor; Tropomyosin related kinase A

Indexed keywords

3,5 DI TERT BUTYL ALPHA CYANO 4 HYDROXYTHIOCINNAMAMIDE; K 252A; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE A; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APPARATUS; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; IMMUNOFLUORESCENCE; KERATINOCYTE; MALE; MOUSE; NERVE FIBER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SCRATCHING; SKIN DEFECT;

ANIMALS; CARBAZOLES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; INDOLE ALKALOIDS; MALE; MICE; MICE, INBRED STRAINS; PRURITUS; RECEPTORS, NERVE GROWTH FACTOR; TREATMENT OUTCOME; TYRPHOSTINS;

EID: 33846192390     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07636.x     Document Type: Article

References (46)

1. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; 92 (Suppl.):44-7.
2. Williams HC, Burney PGJ, Pembroke AC, Hay RJ. The U.K. working party's diagnostic criteria for atopic dermatitis, III. Independent hospital validation. Br J Dermatol 1994; 131:406-16.
3. Kimura T, Miyazawa H. The 'butterfly' sign in patients with atopic dermatitis: evidence for the role of scratching in the development of skin manifestations. J Am Acad Dermatol 1989; 21:579-80.
4. Wahlgren CF. Itch and atopic dermatitis: an overview. J Dermatol 1999; 26:770-9.
5. Koblenzer CS. Itching and the atopic skin. J Allergy Clin Immunol 1999; 104:S109-13.
6. Tobin D, Nabarro G, de la Faille HB et al. Increased number of immunoreactive nerve fibers in atopic dermatitis. J Allergy Clin Immunol 1992; 90:613-22.
7. Urashima R, Mihara M. Cutaneous nerves in atopic dermatitis. Virchows Arch 1998; 432:363-70.
8. Albers KM, Wright DE, Davis BM. Overexpression of nerve growth factor in epidermis of transgenic mice causes hypertrophy of the peripheral nervous system. J Neurosci 1994; 14:1422-32.
9. Leslie TA, Emson PC, Dowd PM et al. Nerve growth factor contributes to the up-regulation of growth-associated protein 43 and preprotachykinin A messenger RNAs in primary sensory neurons following peripheral inflammation. Neuroscience 1995; 67:753-61.
10. Bennett DL, Koltzenburg M, Priestley JV et al. Endogenous nerve growth factor regulates the sensitivity of nociceptors in the adult rat. Eur J Neurosci 1998; 10:1282-91.
11. Ansel JC, Kaynard AH, Armstrong CA et al. Skin-nervous system interactions. J Invest Dermatol 1996; 106:198-204.
12. Pincelli C, Yaar M. Nerve growth factor: its significance in cutaneous biology. J Investig Dermatol Symp Proc 1997; 2:31-6.
13. Johansson O, Liang Y, Emtestam L. Increased nerve growth factorand tyrosine kinase A-like immunoreactivities in prurigo nodularis skin - an exploration of the cause of neurohyperplasia. Arch Dermatol Res 2002; 293:614-19.
14. Fantini F, Magnoni C, Bracci-Laudiero L et al. Nerve growth factor is increased in psoriatic skin. J Invest Dermatol 1995; 105:854-5.
15. Raychaudhuri SP, Jiang WY, Farber EM. Psoriatic keratinocytes express high levels of nerve growth factor. Acta Derm Venereol (Stockh) 1998; 78:84-6.
16. Toyoda M, Nakamura M, Makino T et al. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002; 147:71-9.
17. Matsuda H, Watanabe N, Geba GP et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997; 9:461-6.
18. Tohda C, Yamaguchi T, Kuraishi Y. Increased expression of mRNA for myocyte-specific enhancer binding factor (MEF) 2C in the cerebral cortex of the itching mouse. Neurosci Res 1997; 29:209-15.
19. Suto H, Matsuda H, Mitsuishi K et al. NC/Nga mice: a mouse model for atopic dermatitis. Int Arch Allergy Immunol 1999; 120:70-5.
20. Takano N, Sakurai T, Kurachi M. Effects of anti-nerve growth factor antibody on symptoms in the NC/Nga mouse, an atopic dermatitis model. J Pharmacol Sci 2005; 99:277-86.
21. Johnson D, Lanahan A, Buck CR et al. Expression and structure of the human NGF receptor. Cell 1986; 47:545-54.
22. Kaplan DR, Hempstead BL, Martin-Zanca D et al. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 1991; 252:554-8.
23. Hempstead BL. The many faces of p75NTR. Curr Opin Neurobiol 2002; 12:260-7.
24. Loeb DM, Maragos J, Martin-Zanca D et al. The trk proto-oncogene rescues NGF responsiveness in mutant NGF-nonresponsive PC12 cell lines. Cell 1991; 66:961-6.
25. Hempstead BL, Rabin SJ, Kaplan L et al. Overexpression of the trk tyrosine kinase rapidly accelerates nerve growth factor-induced differentiation. Neuron 1992; 9:883-6.
26. Schechter AL, Bothwell MA. Nerve growth factor receptors on PC12 cells: evidence for two receptor classes with differing cytoskeletal association. Cell 1981; 24:867-74.
27. Barrett GL. The p75 neurotrophin receptor and neuronal apoptosis. Prog Neurobiol 2000; 61:205-29.
28. Hirata H, Hibasami H, Yoshida T et al. Nerve growth factor signaling of p75 induces differentiation and ceramide-mediated apoptosis in Schwann cells cultured from degenerating nerves. Glia 2001; 36:245-58.
29. Miller FD, Kaplan DR. Neurotrophin signaling pathways regulating neuronal apoptosis. Cell Mol Life Sci 2001; 58:1045-53.
30. Koizumi S, Contreras ML, Matsuda Y et al. K252a: a specific inhibitor of the action of nerve growth factor on PC 12 cells. J Neurosci 1988; 8:715-21.
31. Lazarovici P, Levi BZ, Lelkes PI et al. K-252a inhibits the increase in c-fos transcription and the increase in intracellular calcium produced by nerve growth factor in PC12 cells. J Neurosci Res 1989; 23:1-8.
32. Berg MM, Sternberg DW, Parada LF et al. K252a inhibits nerve growth factor induced trk proto-oncogene tyrosine phosphorylation and kinase activity. J Biol Chem 1992; 267:13-16.
33. Ohmichi M, Pang L, Ribon V et al. The tyrosine kinase inhibitor tryphostin blocks the cellular actions of nerve growth factor. Biochemistry 1993; 32:4650-8.
34. Takano N, Arai I, Kurachi M. A method to induce stable atopic dermatitis-like symptoms in NC/Nga mice housed with skin-lesioned mice. Br J Dermatol 2006; 154:426-30.
35. Kuraishi Y, Nagasawa T, Hayashi K et al. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur J Pharmacol 1995; 275:229-33.
36. Yamaguchi T, Maekawa T, Nishikawa Y et al. Characterization of itch-associated responses of NC mice with mite-induced chronic dermatitis. J Dermatol Sci 2001; 25:20-8.
37. Di Marco E, Mathor M, Bondanza S et al. Nerve growth factor binds to normal human keratinocytes through high and low affinity receptors and stimulates their growth by a novel autocrine loop. J Biol Chem 1993; 268:22838-46.
38. Pincelli C, Sevignani C, Manfredini R et al. Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invest Dermatol 1994; 103:13-18.
39. Duimel-Peeters IGP, Houwing RH, Teunissen CP et al. A systematic review of the efficacy of topical skin application of dimethyl sulfoxide on wound healing and as anti-inflammatory drug. Wounds 2003; 15:361-70.
40. Kaplan DR, Miller FD. Signal transduction by the neurotrophin receptors. Curr Opin Cell Biol 1997; 9:213-21.
41. Pincelli C, Haake AR, Benassi L et al. Autocrine nerve growth factor protects human keratinocytes from apoptosis through its high affinity receptor (TRK): a role for BCL-2. J Invest Dermatol 1997; 109:757-64.
42. Pincelli C, Marconi A. Autocrine nerve growth factor in human keratinocytes. J Dermatol Sci 2000; 22:71-9.
43. Hempstead BL, Martin-Zanca D, Kaplan DR et al. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature 1991; 350:678-83.
44. Ross AH, Daou MC, McKinnon CA et al. The neurotrophin receptor, gp75, forms a complex with the receptor tyrosine kinase TrkA. J Cell Biol 1996; 132:945-53.
45. Maliartchouk S, Saragovi HU. Optimal nerve growth factor trophic signals mediated by synergy of TrkA and p75 receptor-specific ligands. J Neurosci 1997; 17:6031-7.
46. Majdan M, Walsh GS, Aloyz R et al. TrkA mediates developmental sympathetic neuron survival in vivo by silencing an ongoing p75NTR-mediated death signal. J Cell Biol 2001; 155:1275-85.